Literature DB >> 8239166

Mast cells modulate acute ozone-induced inflammation of the murine lung.

S R Kleeberger1, J E Seiden, R C Levitt, L Y Zhang.   

Abstract

We hypothesized that mast cells modulate lung inflammation that develops after acute ozone (O3) exposure. Two tests were done: (1) genetically mast-cell-deficient (WBB6F1-W/Wv, WCB6F1-SI/SId) and bone-marrow-transplanted W/Wv mice were exposed to O3 or filtered air, and the inflammatory responses were compared with those of mast-cell-sufficient congenic mice (WBB6F1-(+)/+, WCB6F1-(+)/+); (2) genetically O3-susceptible C57BL/6J mice were treated pharmacologically with putative mast-cell modulators or vehicle, and the O3-induced inflammatory responses were compared. Mice were exposed to 1.75 ppm O3 or air for 3 h, and lung inflammation was assessed by bronchoalveolar lavage (BAL) 6 and 24 h after exposure. Relative to O3-exposed W/Wv and SI/SId mice, the mean numbers of lavageable polymorphonuclear leukocytes (PMNs) and total BAL protein concentration (a marker of permeability) were significantly greater in the respective O3-exposed normal congenic +/+ mice (p < 0.05). Mast cells were reconstituted in W/Wv mice by transplantation of bone marrow cells from congenic +/+ mice, and O3-induced lung inflammation was assessed in the mast-cell-replete W/Wv mice. After O3 exposure, the changes in lavageable PMNs and total protein of mast-cell-replete W/Wv mice were not different from age-matched normal +/+ control mice, and they were significantly greater than those of sham-transplanted W/Wv mice (p < 0.05). Genetically susceptible C57BL/6J mice were pretreated with a mast-cell stabilizer (nedocromil sodium), secretagogue (compound 48/80), or vehicle, and the mice were exposed to O3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239166     DOI: 10.1164/ajrccm/148.5.1284

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice.

Authors:  David I Kasahara; Joel A Mathews; Chan Y Park; Youngji Cho; Gabrielle Hunt; Allison P Wurmbrand; James K Liao; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-14       Impact factor: 5.464

2.  Fibroproliferation and mast cells in the acute respiratory distress syndrome.

Authors:  J M Liebler; Z Qu; B Buckner; M R Powers; J T Rosenbaum
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Ambient ozone and pulmonary innate immunity.

Authors:  Mashael Al-Hegelan; Robert M Tighe; Christian Castillo; John W Hollingsworth
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders.

Authors:  Y Inoue; T E King; S S Tinkle; K Dockstader; L S Newman
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

5.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

6.  IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.

Authors:  Jennifer Kearley; Jonas S Erjefalt; Cecilia Andersson; Ebony Benjamin; Carla P Jones; Annette Robichaud; Sophie Pegorier; Yambasu Brewah; Timothy J Burwell; Leif Bjermer; Peter A Kiener; Roland Kolbeck; Clare M Lloyd; Anthony J Coyle; Alison A Humbles
Journal:  Am J Respir Crit Care Med       Date:  2010-10-22       Impact factor: 21.405

Review 7.  The contribution of mast cells to bacterial and fungal infection immunity.

Authors:  Adrian M Piliponsky; Luigina Romani
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

8.  A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Authors:  Silvia Moretti; Giorgia Renga; Vasilis Oikonomou; Claudia Galosi; Marilena Pariano; Rossana G Iannitti; Monica Borghi; Matteo Puccetti; Marco De Zuani; Carlo E Pucillo; Giuseppe Paolicelli; Teresa Zelante; Jean-Christophe Renauld; Oxana Bereshchenko; Paolo Sportoletti; Vincenzina Lucidi; Maria Chiara Russo; Carla Colombo; Ersilia Fiscarelli; Cornelia Lass-Flörl; Fabio Majo; Gabriella Ricciotti; Helmut Ellemunter; Luigi Ratclif; Vincenzo Nicola Talesa; Valerio Napolioni; Luigina Romani
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

9.  Identification of an ATP/P2X7/mast cell pathway mediating ozone-induced bronchial hyperresponsiveness.

Authors:  Xiaomei Kong; William C Bennett; Corey M Jania; Kelly D Chason; Zachary German; Jennifer Adouli; Samuel D Budney; Brandon T Oby; Catharina van Heusden; Eduardo R Lazarowski; Ilona Jaspers; Scott H Randell; Barry A Hedgespeth; Glenn Cruse; Xiaoyang Hua; Stephen A Schworer; Gregory J Smith; Samir Np Kelada; Stephen L Tilley
Journal:  JCI Insight       Date:  2021-11-08

10.  Chemokine (C-C Motif) Receptor-Like 2 is not essential for lung injury, lung inflammation, or airway hyperresponsiveness induced by acute exposure to ozone.

Authors:  Farhan Malik; Kevin R Cromar; Constance L Atkins; Roger E Price; William T Jackson; Saad R Siddiqui; Chantal Y Spencer; Nicholas C Mitchell; Ikram U Haque; Richard A Johnston
Journal:  Physiol Rep       Date:  2017-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.